The global non-insulin therapies for diabetes market is poised for substantial growth over the next decade, reflecting the rising prevalence of diabetes worldwide and the increasing focus on innovative treatment options beyond insulin. In 2023, the market was valued at approximately US$ 31.8 billion, underscoring the significant demand for alternative therapies that offer better patient...